Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

L.c

Pleuritic chest pain

Publications

Williams EM, Triller DM

Recurrent acute nitrofurantoin-induced pulmonary toxicity.

Pharmacotherapy 2006 May;26;713-8 — 2006 May — 713-8

Linnebur SA, Parnes BL

Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment.

The Annals of pharmacotherapy 2004 Apr;38;612-6 — 2004 Apr — 612-6

Boggess KA, Benedetti TJ, Raghu G

Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature.

Obstetrical & gynecological survey 1996 Jun;51;367-70 — 1996 Jun — 367-70

Jick SS, Jick H, Walker AM, Hunter JR

Hospitalizations for pulmonary reactions following nitrofurantoin use.

Chest 1989 Sep;96;512-5 — 1989 Sep — 512-5